Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 2/2016

01-02-2016 | Editorial

Academic–Industry Research Partnerships: an Emerging Opportunity or Just Smoke and Mirrors?

Authors: Michael Hochman, MD, MPH, Rachael Bedard, MD

Published in: Journal of General Internal Medicine | Issue 2/2016

Login to get access

Excerpt

It is a time of famine for clinical research, and academic investigators have had to hunt for viable funding sources. While inflation-adjusted public funding for biomedical research has declined over the past two decades, private industry’s share of the funding pie has increased by 13 %.1 The pharmaceutical industry has historically been eager to partner with academic investigators both to tap the academic talent pool and to enhance the credibility of its conclusions. In this month’s issue of the JGIM, Tierney et al. consider situations in which academic–industry partnerships might be both ethical and mutually beneficial.2 …
Literature
1.
Moses H 3rd, Matheson DH, Cairns-Smith S, George BP, Palisch C, Dorsey ER. The anatomy of medical research: US and international comparisons. JAMA. 2015;313(2):174–89.CrossRefPubMed
2.
3.
Bodenheimer T. Uneasy alliance – clinical investigators and pharmaceutical industry. N Engl J Med. 2000;342:1539–1544.CrossRefPubMed
4.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR, TECOS Study Group. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;373(3):232–42.CrossRefPubMed
5.
6.
Kroenke K, West SL, Swindle R, et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA. 2001;286:2947–2955.CrossRefPubMed
7.
American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, Am J Psychiatry, vol. 167(supplement)(10). 3rd ed. 2010:1.
8.
Metadata
Title
Academic–Industry Research Partnerships: an Emerging Opportunity or Just Smoke and Mirrors?
Authors
Michael Hochman, MD, MPH
Rachael Bedard, MD
Publication date
01-02-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3527-8

Other articles of this Issue 2/2016

Journal of General Internal Medicine 2/2016 Go to the issue

Editorial

Understanding Seniors’ Choices in Medicare Advantage

Original Research

Burned Out at the Bedside: Patient Perceptions of Physician Burnout in an Internal Medicine Resident Continuity Clinic

Exercises in Clinical Reasoning

Managing Cognitive Load to Uncover an Unusual Cause of Syncope: Exercises in Clinical Reasoning

Editorial

Comparative International Medical Education

Letter to the Editor

Re: Underuse and Overuse of Osteoporosis Screening in a Regional Health System: A Retrospective Cohort Study

Original Research

Unintentional Continuation of Medications Intended for Acute Illness After Hospital Discharge: A Population-Based Cohort Study
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits